Pancreatic Cancer Research

ResearcherLyon 1 UniversitéNo recent work listed

Spiros Kotopoulis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2783-3606; OpenAlex author ID A5026297799. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 4 papers · 2021: 1 paper · 2022: 1 paper

Papers 10

  1. SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma? Co-author DOI 10.3390/pharmaceutics14010098↗
  2. Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical model. Co-author DOI 10.1080/15384047.2021.1881026↗
  3. Sonoporation for Augmenting Chemotherapy of Pancreatic Ductal Adenocarcinoma. First author DOI 10.1007/978-1-4939-9798-5_9↗
  4. Intracellular Cytidine Deaminase Regulates Gemcitabine Metabolism in Pancreatic Cancer Cell Lines. Co-author DOI 10.1124/dmd.119.089334↗
  5. Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells. First author DOI 10.3390/pharmaceutics12020141↗
  6. Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cells. Co-author DOI 10.3390/pharmaceutics12111058↗
  7. Sonoporation with Acoustic Cluster Therapy (ACT®) induces transient tumour volume reduction in a subcutaneous xenograft model of pancreatic ductal adenocarcino… Co-author DOI 10.1016/j.jconrel.2016.11.019↗
  8. A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. First author DOI 10.1016/j.jconrel.2016.10.007↗
  9. Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft. Co-author DOI 10.1007/s11307-013-0672-5↗
  10. Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Co-author DOI 10.1118/1.4808149↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Emmet McCormack · 8 shared papers, 2014–2022 · strength 0.74
  2. Odd Helge Gilja · 7 shared papers, 2013–2022 · strength 0.58
  3. Tormod Karlsen Bjånes · 4 shared papers, 2016–2022 · strength 0.42
  4. Georg Gjorgji Dimcevski · 4 shared papers, 2013–2022 · strength 0.29
  5. Flemming Forsberg · 2 shared papers, 2020–2021 · strength 0.29
  6. Ragnhild Haugse · 2 shared papers, 2020–2022 · strength 0.26
  7. Bettina Riedel · 2 shared papers, 2020 · strength 0.22
  8. Jason W. Castle · 1 shared paper, 2020 · strength 0.19
  9. Michiel Postema · 3 shared papers, 2013–2016 · strength 0.14
  10. Lars Petter Jordheim · 1 shared paper, 2020 · strength 0.11
  11. Dag Hoem · 2 shared papers, 2013–2016 · strength 0.10
  12. John Robert Eisenbrey · 1 shared paper, 2021 · strength 0.10
  13. Teena Dhir · 1 shared paper, 2021 · strength 0.10
  14. Christopher William Schultz · 1 shared paper, 2021 · strength 0.10
  15. Jonathan Robert Brody · 1 shared paper, 2021 · strength 0.10
  16. Anders Molven · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.